Search - tctmd.com

Displaying 161 - 180 of 427

Sort: Relevancy | Date

Presentation TCT 2019

Case #4: OCT-Guided Laser Therapy in ISR

Presenter: Peter O'Kane

September 26, 2019

Presentation TCT 2019

Case #3: Same Strategy With or Without OCT in ISR?

Presenter: Colm Hanratty

September 26, 2019

Presentation TCT 2019

Case #2: ISR Requires Stepwise OCT-Guiding

Presenter: Jacob Odenstedt

September 26, 2019

Presentation TCT 2019

Case #1: OCT Guided Lesion Preparation in ISR

Presenter: Indulis Kumsars

September 26, 2019

Presentation TCT 2019

In-Stent Restenosis: How Does Atherectomy Figure in These Cases?

Presenter: Nicolas Shammas

September 25, 2019

Presentation TCT 2019

TCT 65: Long-Term Outcomes of In-Stent Restenosis Percutaneous Coronary Intervention Among Medicare Beneficiaries

Presenter: Hector Tamez

September 25, 2019

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

Presentation TCT 2019

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

Presenter: Zhaoyang Chen

September 25, 2019

Presentation TCT 2019

TCT 63: Jetstream Atherectomy for the Treatment of In-stent Restenosis of the Femoropopliteal Artery: Preliminary Results of the JET-ISR Study

Presenter: Nicolas Shammas

September 25, 2019

Presentation TCT 2019

TCT 53: Impact of Intravascular Ultrasound Utilization on Outcomes Following Percutaneous Coronary Intervention for In-stent Restenosis

Presenter: Evan Shlofmitz

September 25, 2019

Presentation TCT 2019

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Binita Shah

September 25, 2019

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

Presentation TCT 2018

Case #12: A Case of In-Stent Restenosis Due to a Markedly Under-expanded Stent in a Severely Calcified Lesion

Presenter: Philippe Genereux, Ajay J. Kirtane, Alaide Chieffo, Carlo Di Mario, Stefan Harb, Richard A. Schatz, Sigmund Silber

September 24, 2018

Presentation TCT 2018

Case #10: A Case in Which Intravascular Imaging Demonstrated a Surprising Cause and Guided Treatment of In-stent Restenosis

Presenter: David Erlinge, Gary S. Mintz, Martin W. Bergmann, Marc D. Feldman, Margaret B. McEntegart, Yasunori Ueda, Carlo Zivelonghi, Robert-Jan van Geuns

September 24, 2018

Presentation TCT 2018

Left Main Restenosis and Treatment (With Case Examples)

Presenter: Antonio Colombo, Leif Thuesen, Imad Sheiban

September 23, 2018

Presentation TCT 2018

DCB for Coronary Artery Disease: In-Stent Restenosis, NSTEMI, and Small Vessels

Presenter: Juan F. Granada, Bruno Scheller

September 23, 2018

Presentation TCT 2018

Intravascular Imaging to Evaluate Stent Thrombosis and Restenosis

Presenter: Fernando Alfonso, Hiram G. Bezerra, Lorenz Raber

September 23, 2018

Presentation TCT 2018

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

Presenter: Fernando Alfonso, Juan F. Granada, YunDai Chen

September 23, 2018

News Conference News TCT 2018

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

Michael O'Riordan

September 22, 2018

Advertisement

Case #4: OCT-Guided Laser Therapy in ISR

Case #3: Same Strategy With or Without OCT in ISR?

Case #2: ISR Requires Stepwise OCT-Guiding

Case #1: OCT Guided Lesion Preparation in ISR

In-Stent Restenosis: How Does Atherectomy Figure in These Cases?

TCT 65: Long-Term Outcomes of In-Stent Restenosis Percutaneous Coronary Intervention Among Medicare Beneficiaries

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

TCT 63: Jetstream Atherectomy for the Treatment of In-stent Restenosis of the Femoropopliteal Artery: Preliminary Results of the JET-ISR Study

TCT 53: Impact of Intravascular Ultrasound Utilization on Outcomes Following Percutaneous Coronary Intervention for In-stent Restenosis

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Case #12: A Case of In-Stent Restenosis Due to a Markedly Under-expanded Stent in a Severely Calcified Lesion

Case #10: A Case in Which Intravascular Imaging Demonstrated a Surprising Cause and Guided Treatment of In-stent Restenosis

Left Main Restenosis and Treatment (With Case Examples)

DCB for Coronary Artery Disease: In-Stent Restenosis, NSTEMI, and Small Vessels

Intravascular Imaging to Evaluate Stent Thrombosis and Restenosis

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content